CSIMarket Company Name, Ticker, Competitors, else..


Mirati Therapeutics Inc   (NASDAQ: MRTX)
Other Ticker:  
 

Mirati Therapeutics Inc

MRTX's Fundamental analysis



Looking into Mirati Therapeutics Inc growth rates, revenue grew by 201.97 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 128

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.76 %

Mirati Therapeutics Inc net loss decreased from $-174 millions, to $-162 millions in III. Quarter 2023,

• More on MRTX's Growth


Mirati Therapeutics Inc
realized a net loss in trailing twelve months.

Mirati Therapeutics Inc realized cash reduction of $ -0.62 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 99.9.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.


• More on MRTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 84,869
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.73
 Tangible Book Value (Per Share $) 14.35

Mirati Therapeutics Inc
realized net loss in trailing twelve months.

Mirati Therapeutics Inc realized cash outflow of $ -0.62per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 99.9.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.

Mirati Therapeutics Inc Price to Book Ratio is at 4.03 lower than Industry Avg. of 431.19. and higher than S&P 500 Avg. of 0.01

• More on MRTX's Valuation

•  Market Capitalization (Millions $) 3,815
•  Shares Outstanding (Millions) 65
•  Employees 450
•  Revenues (TTM) (Millions $) 38
•  Net Income (TTM) (Millions $) -726
•  Cash Flow (TTM) (Millions $) -40
•  Capital Exp. (TTM) (Millions $) -2
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 84,869
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4.73
•  Tangible Book Value (Per Share $) 14.35

•  Market Capitalization (Millions $) 3,815
•  Shares Outstanding (Millions) 65
•  Employees 450
•  Revenues (TTM) (Millions $) 38
•  Net Income (TTM) (Millions $) -726
•  Cash Flow (TTM) (Millions $) -40
•  Capital Exp. (TTM) (Millions $) -2





  Ratio
•   Capital Ratio (MRQ) 7.54
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.2
•  Asset Turnover Ratio (TTM) 0.04
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com